Jill Murphy, Assistant Editor

Cyclin-dependent kinase 4/6 inhibitors offer the potential to significantly improve outcomes for women with HR-positive, HER2-negative breast cancer.

The consumption of these antibiotics may lead to dangerous unintended consequences, such as adverse effects that include treatment failures, and antibiotic drug resistance.

The FDA has granted Fast Track Designation for the development of PH94B (VistaGen Therapeutics), a neuroactive nasal spray for on-demand treatment of social anxiety disorder (SAD).

The FDA has approved the Unidose Liquid System (AptarGroup Inc) as the first and only nasal rescue treatment for acute repetitive seizures in patients with epilepsy.

The US Department of Health and Human Services (HHS) has entered an agreement with Sanofi Pasteur to increase the company's domestic pandemic influenza vaccine production capabilities.

Four healthcare practitioners have been recognized by the American Society of Health-System Pharmacists (ASHP) with different leadership awards. The honorees were presented with the awards during specific ceremonies at the ASHP Midyear Clinical Meeting and Exhibition in Las Vegas.

According to Janet Woodcock, MD and director of FDA’s Center for Drug Evaluation and Research, the agency is focused on the drugs used by Americans continuing to meet “strict quality standards.”

Louisiana, Nevada, Texas rank highest in flu activity for the month of November.

Emmes, a scientific research company, will support the development of a universal influenza vaccine that could provide longer-lasting protection than the current vaccines available.

Officials from the FDA have approved methotrexate (RediTrex, Cumberland Pharmaceuticals) as an injection for the treatment of adult and pediatric patients with rheumatoid arthritis.

Staying on top of oral hygiene may be connected to a lower risk of atrial fibrillation and heart failure.

Since 2005, the CDC has enforced National Influenza Vaccination Week to emphasize the importance of continuing flu vaccination even through the winter months. Although it is the holiday season, the CDC and other organizations want to remind the general public that it is never a bad time to get your flu vaccine. Sam Nass, PharmD, MBS and Walgreens Immunizations Manager weighed in on the subject in an interview with Pharmacy Times®.

Trastuzumab-dkst (Ogivri, Mylan, Biocon), a biosimilar to trastuzumab (Herceptin, Genentech Inc.), has been launched in the US, according to an announcement from Mylan N.V. and Biocon Ltd. It is the first biosimilar approved by the FDA and recommended by the FDA Oncologic Drugs Advisory Committee.

A randomized clinical trial published by JAMA Internal Medicine found that the distribution of HIV self-tests is a useful source for increasing awareness of HIV infection, and for preventing future transmission, specifically among men having sex with men.

Each November, members of the chronic obstructive pulmonary disease (COPD) community come together to focus on increasing awareness of the respiratory condition.

A study published in the Clinical Journal of American Society of Nephrology found that a healthy dietary pattern may prevent chronic kidney disease (CKD) and albuminuria.

FDA draft guidance allows for an animal drug to be compounded from bulk drug substances in limited circumstances for which there is no FDA-approved treatment.

Officials from the FDA have approved MiSight 1-day contact lenses (CooperVision), a daily wear, single use contact lens indicated for the use of myopia management. This is the first FDA-approved product clinically proven to slow the progression of myopia, or near-sightedness, when initially prescribed for children ages 8-12 years.

Officials with the FDA have approved adalimumab-afzb (Abrilada, Pfizer), a biosimilar to Humira, for the treatment of certain patients with rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn disease, ulcerative colitis, and plaque psoriasis.

The American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting is approaching, and Pharmacy Times® will be on-site to provide comprehensive coverage from Las Vegas, Nevada. ASHP Midyear 2019 will take place December 8 to 12, 2019.

In honor of World Diabetes Day, AstraZeneca has launched the campaign Diabetes Can Break Your Heart, the national movement aimed to change the trajectory of heart failure in type 2 diabetes.

Receiving a flu shot before a heart bypass surgery can stop inflammation throughout the body and possibly lead to a healthier recovery, according to a preliminary study presented at the American Heart Association’s Scientific Sessions in Philadelphia, Pennsylvania.

A study presented at the 2019 ACR/ARP Annual Meeting highlights the need for additional medications for the treatment of juvenile idiopathic arthritis in children.

A study conducted by the Uniting Medically Supervised Injecting Centre in Sydney, Australia found that intranasally administered naloxone can reverse opioid overdose, but not as efficiently as intramuscularly administered naloxone can.

A supplemental New Drug Application (sNDA) was submitted to the FDA for ibrutinib (Imbruvica, AbbVie) in combination with rituximab for the first-line treatment of younger patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

Louisiana and Nevada show the highest flu activity in the first monthly report from the Walgreens Flu Index for October, which shows increased incidence of the flu compared with last year.

According to a study by PMR, the global flu vaccine market is projected to account for a market value of approximately $8 billion by the end of 2029. Increasing vaccination rates and a focus on preventive rather than reactive methods are expected to drive the growth of the market.

According to a new study by researchers at The Lundquist Institute and the University of Rochester, e-cigarette or vaping use can damage the lungs after as little as 3 days of use.

In the studies of Biktarvy from Gilead Sciences, the treatment demonstrated high rates of virologic suppression through week 144 and was found to be well-tolerated.

In 2019, the popularity of self-reported e-cigarette use was high among high school and middle school students, with many current e-cigarette users reporting frequent use and most of the exclusive users reporting use of flavored e-cigarettes.